Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial | Communications Medicine
A 2026 pilot trial shows psilocybin-assisted therapy is safe and feasible for veterans with severe, treatment-resistant PTSD. Here's what it…
Aug 26, 2026